Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
Arch Capital
ACGL
$32.6B
| $12.4M | 0.01% |
433,696
-2,315,204
| -84% | -$64M |
2014 Q2
24 quarters
|
|
1102
Cheesecake Factory
CAKE
$5.4B
| $12.4M | 0.01% |
+541,145
| New | +$11.4M |
2020 Q2
0 quarters
|
|
1103
Maximus
MMS
$3.11B
| $12.4M | 0.01% |
175,900
+34,700
| +25% | +$2.33M |
2017 Q4
10 quarters
|
|
1104
SFL Corp
SFL
$1.85B
| $12.4M | 0.01% |
1,331,565
+5,468
| +0.4% | +$54.7K |
2017 Q3
11 quarters
|
|
|
CIT
1105
DELISTED
CIT Group Inc.
CIT
| $12.4M | 0.01% |
+596,102
| New | +$11.5M |
2020 Q2
0 quarters
|
|
|
SHI
1106
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $12.3M | 0.01% |
516,217
+54,900
| +12% | +$1.42M |
2015 Q4
18 quarters
|
|
1107
iShares Core US Aggregate Bond ETF
AGG
$137B
| $12.3M | 0.01% |
103,700
+89,300
| +620% | +$10.5M |
2020 Q1
1 quarter
|
|
1108
DELISTED
CyberArk
CYBR
| $12.2M | 0.01% |
123,388
+85,088
| +222% | +$8.28M |
2020 Q1
1 quarter
|
|
|
HDS
1109
DELISTED
HD Supply Holdings, Inc.
HDS
| $12.2M | 0.01% |
353,100
+163,800
| +87% | +$5.08M |
2017 Q4
10 quarters
|
|
1110
Invesco Ultra Short Duration ETF
GSY
$3.86B
| $12.2M | 0.01% |
242,500
+114,000
| +89% | +$5.71M |
2018 Q2
8 quarters
|
|
|
TNAV
1111
DELISTED
Telenav Inc.
TNAV
| $12.2M | 0.01% |
2,224,491
+93,800
| +4% | +$464K |
2013 Q2
28 quarters
|
|
1112
Methode Electronics
MEI
$554M
| $12.2M | 0.01% |
389,680
-29,400
| -7% | -$881K |
2013 Q2
28 quarters
|
|
1113
DELISTED
Adverum Biotechnologies
ADVM
| $12.2M | 0.01% |
58,295
-50,120
| -46% | -$8.88M |
2015 Q4
18 quarters
|
|
|
QVCGA
1114
DELISTED
QVC Group Inc Series A
QVCGA
| $12.2M | 0.01% |
+26,357
| New | +$10.3M |
2020 Q2
0 quarters
|
|
1115
Star Group
SGU
$426M
| $12.2M | 0.01% |
1,385,655
+93,300
| +7% | +$736K |
2016 Q1
17 quarters
|
|
|
CLGX
1116
DELISTED
Corelogic, Inc.
CLGX
| $12.1M | 0.01% |
180,096
-714,814
| -80% | -$31.8M |
2017 Q2
12 quarters
|
|
1117
Mativ Holdings
MATV
$640M
| $12.1M | 0.01% |
361,098
-221,000
| -38% | -$6.65M |
2013 Q2
28 quarters
|
|
1118
Bread Financial
BFH
$3.86B
| $12M | 0.01% |
+334,604
| New | +$11.9M |
2020 Q2
0 quarters
|
|
1119
McGrath RentCorp
MGRC
$2.78B
| $12M | 0.01% |
222,603
-132,200
| -37% | -$7.1M |
2014 Q4
22 quarters
|
|
1120
AeroVironment
AVAV
$6.97B
| $12M | 0.01% |
+150,439
| New | +$9.69M |
2020 Q2
0 quarters
|
|
1121
Freedom Holding
FRHC
$10.8B
| $12M | 0.01% |
640,909
+481,700
| +303% | +$8M |
2019 Q4
2 quarters
|
|
1122
Enterprise Financial Services Corp
EFSC
$2.12B
| $12M | 0.01% |
384,700
-105,700
| -22% | -$3.07M |
2013 Q3
27 quarters
|
|
1123
DELISTED
Lakeland Bancorp Inc
LBAI
| $11.9M | 0.01% |
1,040,600
-107,600
| -9% | -$1.16M |
2014 Q1
25 quarters
|
|
1124
DELISTED
Sage Therapeutics
SAGE
| $11.9M | 0.01% |
285,800
-461,332
| -62% | -$16.7M |
2019 Q4
2 quarters
|
|
|
CO
1125
DELISTED
Global Cord Blood Corporation
CO
| $11.8M | 0.01% |
3,817,062
+576,864
| +18% | +$1.68M |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.